Due to the Market BIT225 is worth $Billions

This just dawned on me. We have all forget one major factor. Competition. You have 2 big sellers of drugs. What’s BIT worth for one to get and the other one not to?

If Gilead buys BIT and partners it with their drug, it’s the end of GSK’s business in HIV drugs. And visa versa.

There is is much more in play than you think. This could easily turn into a bidding war were the loser goes out of business.

What’s that worth in a market worth $20 Billion a year and growing.

Not just that, risk management from both parties stipulate they almost need to hedge their bets just in case.

This could get very very interesting. (Btw, I started a new thread due to the enormity of the concept)